Open access
Sep 2026
Targeting the DNHD1-HDAC6 axis inactivates prostate cancer cell aggressiveness in vitro, suggesting potential therapeutic vulnerability
It is implied that in prostate cancer, the DNHD1-HDAC6 axis, a novel regulatory pathway, promotes aggressiveness and that HDAC6 is a targetable mediator of DNHD1-driven malignancy.
An-Nie-On-Nei Lee, Chia-Chang Wu, Su-Wei Hu et al.
· Oncology Report · 0 citations